Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q26740323)
Watch
English
Management of HBV and HBV/HDV-Associated Liver Cirrhosis
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
review article
1 reference
stated in
Europe PubMed Central
title
Management of HBV and HBV/HDV-Associated Liver Cirrhosis
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
main subject
liver cirrhosis
0 references
author
Markus Cornberg
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
Christoph Höner Zu Siederdissen
series ordinal
1
object named as
Christoph Höner Zu Siederdissen
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
language of work or name
English
0 references
publication date
12 April 2016
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
published in
Visceral medicine
2 references
stated in
PubMed
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
volume
32
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
issue
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
page(s)
86-94
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
cites work
High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
7 April 2017
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Long-Term Telbivudine Treatment Results in Resolution of Liver Inflammation and Fibrosis in Patients with Chronic Hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Trained immunity in newborn infants of HBV-infected mothers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Long-term therapy of chronic delta hepatitis with peginterferon alfa.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Strategies to inhibit entry of HBV and HDV into hepatocytes.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Development and evaluation of a baseline-event-anticipation score for hepatitis delta
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Hepatitis delta virus induces specific DNA methylation processes in Huh-7 liver cancer cells
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Treatment options for hepatitis delta virus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Basal core promoter mutation is associated with progression to cirrhosis rather than hepatocellular carcinoma in chronic hepatitis B virus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Hepatitis delta and HIV infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Hepatitis B virus-related cirrhosis: natural history and treatment
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 September 2017
Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
The role of HBsAg levels in the current management of chronic HBV infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
HBsAg seroclearance with NUCs: rare but important.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
31 May 2018
Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Comparison of the efficacies of lamivudine versus entecavir in patients with hepatitis B virus-related decompensated cirrhosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: An international multicenter cohort study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Efficacy of entecavir in treatment-naïve patients with hepatitis B virus-related decompensated cirrhosis.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4926882
retrieved
28 November 2018
Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Hepatitis delta virus
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Peginterferon plus adefovir versus either drug alone for hepatitis delta
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/27413725
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1159/000445518
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
PMC publication ID
4926882
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
PubMed publication ID
27413725
1 reference
stated in
Europe PubMed Central
PMC publication ID
4926882
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27413725%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
